Patents by Inventor Padmanabh Bhatt

Padmanabh Bhatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride
    Publication number: 20100221353
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw KIDANE, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
    Publication number: 20100221354
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
    Publication number: 20100221355
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw KIDANE, Henry H. FLANNER, Padmanabh BHATT, Arash RAOUFINIA
  • Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration
    Publication number: 20100222375
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw KIDANE, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE
    Publication number: 20100221352
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw KIDANE, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE
    Publication number: 20100221356
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: May 12, 2010
    Publication date: September 2, 2010
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw KIDANE, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Patent number: 7781448
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: August 24, 2010
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Trospium chloride treatment method
    Patent number: 7781449
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: August 24, 2010
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Patent number: 7763635
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: July 27, 2010
    Assignee: Supermus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Method of treating bladder dysfunction with once-a-day trospium salt formulation
    Patent number: 7759359
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: July 20, 2010
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207661
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207662
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207663
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207664
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Patent number: 7410978
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: November 4, 2004
    Date of Patent: August 12, 2008
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Osmotic drug delivery system
    Publication number: 20070254032
    Abstract: An oral osmotic pharmaceutical delivery system comprises a highly water-soluble drug exhibiting an erratic or an incomplete release profile when formulated in a elementary osmotic pump delivery system and at least one release enhancing agent.
    Type: Application
    Filed: April 27, 2006
    Publication date: November 1, 2007
    Inventors: Argaw Kidane, Padmanabh Bhatt
  • Orally administrable extended release pellet and tablet formulations of a highly water soluble compound
    Publication number: 20070134315
    Abstract: Pharmaceutical compositions comprising an extended release formulation of active compounds effective in the treatment of various pathological conditions are provided. More particularly, the invention provides methods of making and using extended release formulations comprising active compounds that present formulation challenges such as short biological half-life, instability, highly water soluble and/or high dose requirements. Specifically, orally administrable extended release pellet and tablet formulations of isovaleramide are preferred.
    Type: Application
    Filed: December 8, 2005
    Publication date: June 14, 2007
    Inventors: Michael Viera, Padmanabh Bhatt, Lisa McKnight, Abraham Woldu, Goutam Muhuri
  • Controlled release compositions of gamma-hydroxybutyrate
    Publication number: 20060210630
    Abstract: The present invention is directed to oral pulse-release pharmaceutical dosage form containing an immediate release component of gamma-hydroxybutyric acid, and one or more delayed/controlled release components of gamma-hydroxybutyric acid.
    Type: Application
    Filed: September 30, 2005
    Publication date: September 21, 2006
    Inventors: Likan Liang, Niraj Shah, Padmanabh Bhatt, Scott Ibrahim
  • Once daily dosage forms of trospium
    Publication number: 20050191351
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: November 4, 2004
    Publication date: September 1, 2005
    Applicant: Shire Laboratories, Inc.
    Inventors: Argaw Kidane, Henry Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Controlled delivery of active agents
    Publication number: 20050136113
    Abstract: Controlled release of active agents from sustained release push delivery devices having high drug loading are described wherein residual drug content in the device is minimized by the utilization of a flow-promoting layer between a semi-permeable wall and drug layer comprising the device.
    Type: Application
    Filed: February 4, 2005
    Publication date: June 23, 2005
    Inventors: Padmanabh Bhatt, Evangeline Cruz, Noymi Yam